AIMS: Mobile Airways Sentinel NetworK (MASK) belongs to the Fondation Partenariale MACVIA-LR of Montpellier, France and aims to provide an active and healthy life to rhinitis sufferers and to those with asthma multimorbidity across the life cycle, whatever their gender or socio-economic status, in order to reduce health and social inequities incurred by the disease and to improve the digital transformation of health and care. The ultimate goal is to change the management strategy in chronic diseases. METHODS: MASK implements ICT technologies for individualized and predictive medicine to develop novel care pathways by a multi-disciplinary group centred around the patients. STAKEHOLDERS: Include patients, health care professionals (pharmacists and physicians), authorities, patient's associations, private and public sectors. RESULTS: MASK is deployed in 23 countries and 17 languages. 26,000 users have registered. EU GRANTS 2018: MASK is participating in EU projects (POLLAR: impact of air POLLution in Asthma and Rhinitis, EIT Health, DigitalHealthEurope, Euriphi and Vigour). LESSONS LEARNT: (i) Adherence to treatment is the major problem of allergic disease, (ii) Self-management strategies should be considerably expanded (behavioural), (iii) Change management is essential in allergic diseases, (iv) Education strategies should be reconsidered using a patient-centred approach and (v) Lessons learnt for allergic diseases can be expanded to chronic diseases.

Academic Medical Center Univ of Amsterdam Amsterdam The Netherlands

Allergist La Rochelle France

Allergist Mexico City Mexico

Allergist Reims France

Allergy Center CUF Descobertas Hospital Lisbon Portugal

Allergy Department 2nd Pediatric Clinic Athens General Children's Hospital P and A Kyriakou University of Athens Athens Greece

Allergy Department Pasteur Institute Paris France

Allergy Section Department of Internal Medicine Hospital Vall 'dHebron and ARADyAL Research Network Barcelona Spain

Allergy Unit Department of Dermatology University Hospital of Zurich Zurich Switzerland

Association Asthme et Allergie Paris France

Association of Finnish Pharmacies Helsinki Finland

Asthma Reference Center Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria Vitória Esperito Santo Brazil

Asthma UK Centre for Applied Research The Usher Institute of Population Health Sciences and Informatics The University of Edinburgh Edinburgh UK

Asthma UK Mansell Street London UK

Berlin Institute of Health Comprehensive Allergy Centre Department of Dermatology and Allergy Member of GA2LEN Berlin Germany

Center for Research in Health Technology and Information Systems Faculdade de Medicina da Universidade do Porto Medida Lda Porto Portugal

Center for Rhinology and Allergology Wiesbaden Germany

Center of Excellence in Asthma and Allergy Médica Sur Clinical Foundation and Hospital Mexico City Mexico

Centre for Clinical Research Sörmland Uppsala University Eskilstuna Sweden

CHU de Grenoble Grenoble France

CHU Dijon Dijon France

CIBER Epidemiología y Salud Pública Barcelona Spain

CIRFF Federico 2 University Naples Italy

Clinic of Children's Diseases and Institute of Health Sciences Department of Public Health Vilnius University Institute of Clinical Medicine Vilnius Lithuania

Clinic of Children's Diseases Faculty of Medicine Vilnius University Vilnius Lithuania

Clinic of Infectious Chest Diseases Dermatology and Allergology Vilnius University Vilnius Lithuania

Clinical and Experimental Respiratory Immunoallergy IDIBAPS CIBERES University of Barcelona Barcelona Spain

Clinical Medecine Laval's University Quebec City Canada

Clinical Reserch Center for Allergy and Rheumatology Sagamihara National Hospital Sagamihara Japan

Conseil Général de l'Economie Ministère de l'Economie de l'Industrie et du Numérique Paris France

Consortium of Pharmacies and Services COSAFER Salerno Italy

Corporate Member of Freie Universität Berlin Humboldt Uniersität zu Berlin Charité Universitätsmedizin Berlin Berlin Germany

CRI Clinical Research International Ltd Hamburg Germany

Department of Allergy and Immunology Hospital Quirón Bizkaia Erandio Spain

Department of Allergy Immunology and Respiratory Medicine Alfred Hospital and Central Clinical School Monash University Melbourne VIC Australia

Department of Clinical Science and Education Södersjukhuset Karolinska Institutet Stockholm Sweden

Department of Dermatology and Allergy Centre Odense University Hospital Odense Research Center for Anaphylaxis Odense Denmark

Department of ENT Medical University of Graz Graz Austria

Department of Geriatrics Montpellier University Hospital Montpellier France

Department of Health Research Methods Evidence and Impact Division of Immunology and Allergy McMaster University Hamilton ON Canada

Department of Immunology Monash University Melbourne VIC Australia

Department of Internal Medicine and Allergic Clinic of Professor Polydoro Ernani de Sao Thiago University Hospital Federal University of Santa Catarina Florianópolis Brazil

Department of Internal Medicine Medical University of Graz Graz Austria

Department of Lung Diseases and Clinical Immunology Terveystalo Allergy Clinic University of Turku Turku Finland

Department of Medical Sciences Allergy and Clinical Immunology Unit University of Torino and Mauriziano Hospital Turin Italy

Department of Medicine Clinical Immunology and Allergy McMaster University Hamilton ON Canada

Department of Medicine Surgery and Dentistry Scuola Medica Salernitana University of Salerno Salerno Italy

Department of Otolaryngology Head and Neck Surgery University of Mainz Mainz Germany

Department of Otorhinolaryngology Amsterdam University Medical Centre Amsterdam The Netherlands

Department of Otorhinolaryngology Chiba University Hospital Chiba Japan

Department of Otorhinolaryngology Head and Neck Surgery Section of Rhinology and Allergy University Hospital Marburg Phillipps Universität Marburg Marburg Germany

Department of Otorhinolaryngology Univ Hospitals Leuven Louvain Belgium

Department of Otorhinolaryngology University of Crete School of Medicine Heraklion Greece

Department of Prevention of Envinronmental Hazards and Allergology Medical University of Warsaw Warsaw Poland

Department of Public Health and Primary Care Leiden University Medical Center Leiden The Netherlands

Department of Pulmonary Diseases Cerrahpasa Faculty of Medicine Istanbul University Cerrahpasa Istambul Turkey

Department of Pulmonary Diseases Faculty of Medicine Celal Bayar University Manisa Turkey

Department of Respiratory Medicine Ghent University Hospital Ghent Belgium

Department of Respiratory Medicine University Hospital Olomouc Olomouc Czech Republic

Director of Center of Allergy Immunology and Respiratory Diseases Santa Fe Argentina Center for Allergy and Immunology Santa Fe Argentina

Division for Health Innovation Campania Region and Federico 2 University Hospital Naples Naples Italy

Division of Allergy Immunology University of South Florida Tampa USA

Division of Infection Immunity and Respiratory Medicine Royal Manchester Children's Hospital University of Manchester Manchester UK

Division of Internal Medicine Asthma and Allergy Barlicki University Hospital Medical University of Lodz Lodz Poland

EA 2991 Euromov University Montpellier Montpellier France

EFA European Federation of Allergy and Airways Diseases Patients' Associations Brussels Belgium

Epidemiology of Allergic and Respiratory Diseases Department Institute Pierre Louis of Epidemiology and Public Health INSERM Sorbonne Université Medical School Saint Antoine Paris France

Euforea Brussels Belgium

European Academy of Paediatrics Brussels Belgium

Faculty of Health Sciences and CICS UBI Health Sciences Research Centre University of Beira Interior Covilhã Portugal

Faculty of Medicine Transylvania University Brasov Romania

Faculty of Medicine Vilnius University Vilnius Lithuania

FILHA Finnish Lung Association Helsinki Finland

Health Planning Unit Department of Social Medicine Faculty of Medicine University of Crete Crete Greece

Honorary Clinical Research Fellow Allergy and Respiratory Research Group Usher Institute of Population Health Sciences and Informatics Medical School University of Edinburgh Edinburgh UK

Honorary Research Fellow OPC Cambridge UK

Hospital General Regional 1 Dr Carlos Mc Gregor Sanchez Navarro IMSS Mexico City Mexico

Humboldt Universität zu Berlin Berlin Institute of Health Comprehensive Allergy Center Department of Dermatology and Allergy Charité Universitätsmedizin Berlin Berlin Germany

IMIM Barcelona Spain

Imunoalergologia Centro Hospitalar Universitário de Coimbra and Faculty of Medicine University of Coimbra Coimbra Portugal

INSERM U 1168 VIMA Ageing and Chronic Diseases Epidemiological and Public Health Approaches Villejuif Université Versailles St Quentin en Yvelines UMR S 1168 Montigny Le Bretonneux France

Inserm U1061 Montpellier France

Institute of Medical Statistics and Computational Biology Medical Faculty University of Cologne Cologne Germany

International Primary Care Respiratory Group IPCRG Aberdeen Scotland UK

iQ4U Consultants Ltd London UK

ISGlobAL Centre for Research in Environmental Epidemiology Barcelona Spain

Johns Hopkins School of Medicine Baltimore MD USA

KYomed INNOV Montpellier France

Laboratoire HP2 Grenoble INSERM U1042 Université Grenoble Alpes Grenoble France

MACVIA France Fondation Partenariale FMC VIA LR CHU Arnaud de Villeneuve 371 Avenue du Doyen Gaston Giraud 34295 Montpellier Cedex 5 France

Medecine Department Hôpital de la Malbaie Quebec Canada

Medical Communications Consultant MedScript Ltd Dundalk Ireland

Medical Consulting Czarlewski Levallois France

Nova Southeastern University Fort Lauderdale FL USA

Peercode BV Geldermalsen The Netherlands

Personalized Medicine Clinic Asthma and Allergy Humanitas Research Hospital Humanitas University Rozzano Milan Italy

Pneumologie et Soins Intensifs Respiratoires Hôpitaux Universitaires Paris Centre Hôpital Cochin Paris France

ProAR Nucleo de Excelencia em Asma Federal University of Bahia Vitória da Conquista Brazil

Quebec Heart and Lung Institute Laval University Québec City QC Canada

Rhinology Unit and Smell Clinic ENT Department Hospital Clínic University of Barcelona Barcelona Spain

Sachs' Children and Youth Hospital Södersjukhuset Stockholm and Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden

Section of Allergy and Immunology Saint Louis University School of Medicine Saint Louis MO USA

Servicio de Alergia e Immunologia Clinica Santa Isabel Buenos Aires Argentina

Skin and Allergy Hospital Helsinki University Hospital University of Helsinki Helsinki Finland

Sleep Unit Department of Neurology Hôpital Gui de Chauliac Montpellier Montpellier France

SOS Allergology and Clinical Immunology USL Toscana Centro Prato Italy

The Usher Institute of Population Health Sciences and Informatics The University of Edinburgh Edinburgh UK

UCIBIO REQUINTE Faculty of Pharmacy and Competence Center on Active and Healthy Ageing University of Porto Porto Portugal

Unit of Geriatric Immunoallergology University of Bari Medical School Bari Italy

Universidad Católica de Córdoba Córdoba Argentina

Universitat Pompeu Fabra Barcelona Spain

University of Sydney and Woolcock Emphysema Centre and Local Health District Woolcock Institute of Medical Research Glebe NSW Australia

Upper Airways Research Laboratory ENT Dept Ghent University Hospital Ghent Belgium

UPRES EA220 Pôle des Maladies des Voies Respiratoires Hôpital Foch Université Paris Saclay Suresnes France

WHO GARD Planning Group Salvador Brazil

Erratum v

Clin Transl Allergy. 2019 Oct 9;9:52. doi: 10.1186/s13601-019-0291-6. PubMed

Zobrazit více v PubMed

Bousquet J, Arnavielhe S, Bedbrook A, Bewick M, Laune D, Mathieu-Dupas E, et al. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence. Clin Transl Allergy. 2018;8:45. PubMed PMC

Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(5 Suppl):S147–S334. PubMed

Bousquet J, Schunemann HJ, Samolinski B, Demoly P, Baena-Cagnani CE, Bachert C, et al. Allergic rhinitis and its impact on asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol. 2012;130(5):1049–1062. PubMed

Bousquet J, Anto JM, Annesi-Maesano I, Dedeu T, Dupas E, Pepin JL, et al. POLLAR: impact of air pollution on asthma and rhinitis; a European Institute of Innovation and Technology Health (EIT Health) project. Clin Transl Allergy. 2018;8:36. PubMed PMC

Bousquet J, Hellings PW, Agache I, Amat F, Annesi-Maesano I, Ansotegui IJ, et al. ARIA Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology. J Allergy Clin Immunol. 2018:10.1016/j.jaci.2018.08.049. PubMed

Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A, et al. Integrated care pathways for airway diseases (AIRWAYS-ICPs) Eur Respir J. 2014;44(2):304–323. PubMed

Bousquet J, Barbara C, Bateman E, Bel E, Bewick M, Chavannes NH, et al. AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation. Eur Respir J. 2016;47(4):1028–1033. PubMed

Bousquet J, Hellings PW, Agache I, Bedbrook A, Bachert C, Bergmann KC, et al. ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy. 2016;6:47. PubMed PMC

Courbis AL, Murray RB, Arnavielhe S, Caimmi D, Bedbrook A, Van Eerd M, et al. Electronic clinical decision support system for allergic rhinitis management: MASK e-CDSS. Clin Exp Allergy. 2018;48(12):1640–1653. PubMed

Caimmi D, Baiz N, Tanno LK, Demoly P, Arnavielhe S, Murray R, et al. Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control. Clin Exp Allergy. 2017;47(12):1526–1533. PubMed

Bousquet J, Bewick M, Arnavielhe S, Mathieu-Dupas E, Murray R, Bedbrook A, et al. Work productivity in rhinitis using cell phones: The MASK pilot study. Allergy. 2017;72(10):1475–1484. PubMed

Bousquet J, Caimmi DP, Bedbrook A, Bewick M, Hellings PW, Devillier P, et al. Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study. Allergy. 2017;72(6):857–865. PubMed

Bousquet J, Arnavielhe S, Bedbrook A, Fonseca J, Morais Almeida M, Todo Bom A, et al. The ARIA score of allergic rhinitis using mobile technology correlates with quality-of-life: The MASK study. Allergy. 2017;73(2):505–510. PubMed

Bousquet J, Onorato GL, Bachert C, Barbolini M, Bedbrook A, Bjermer L, et al. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report. Clin Transl Allergy. 2017;7:37. PubMed PMC

Hellings PW, Borrelli D, Pietikainen S, Agache I, Akdis C, Bachert C, et al. European summit on the prevention and self-management of chronic respiratory diseases: report of the European Union Parliament Summit (29 March 2017) Clin Transl Allergy. 2017;7:49. PubMed PMC

Cingi C, Gevaert P, Mosges R, Rondon C, Hox V, Rudenko M, et al. Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report. Clin Transl Allergy. 2017;7:17. PubMed PMC

Bousquet J, Schunemann HJ, Fonseca J, Samolinski B, Bachert C, Canonica GW, et al. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy. 2015;70(11):1372–1392. PubMed

Bousquet J, Khaltaev N. Global surveillance, prevention and control of chronic respiratory diseases. a comprehensive approach. Global Alliance against Chronic Respiratory Diseases. World Health Organization. ISBN 978 92 4 156346 8. 2007:148 p.

Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) Allergy. 2008;63(Suppl 86):8–160. PubMed

Vandenplas O, Vinnikov D, Blanc PD, Agache I, Bachert C, Bewick M, et al. Impact of rhinitis on work productivity: a systematic review. J Allergy Clin Immunol Pract. 2018;6(4):1274–1286. PubMed

Bousquet J, Anto JM, Berkouk K, Gergen P, Antunes JP, Auge P, et al. Developmental determinants in non-communicable chronic diseases and ageing. Thorax. 2015;70(6):595–597. PubMed PMC

Fonseca JA, Nogueira-Silva L, Morais-Almeida M, Azevedo L, Sa-Sousa A, Branco-Ferreira M, et al. Validation of a questionnaire (CARAT10) to assess rhinitis and asthma in patients with asthma. Allergy. 2010;65(8):1042–1048. PubMed

Bousquet J, Agache I, Aliberti MR, Angles R, Annesi-Maesano I, Anto JM, et al. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - Reference Site Twinning (EIP on AHA) Allergy. 2017;73(1):77–92. PubMed

Agache I, Deleanu D, Khaltaev N, Bousquet J. Allergic rhinitis and its impact upon asthma–update (ARIA 2008). Romanian perspective. Pneumologia. 2009;58(4):255–258. PubMed

Bachert C, Jorissen M, Bertrand B, Khaltaev N, Bousquet J. Allergic Rhinitis and its impact on asthma update (ARIA 2008). The Belgian perspective. B-ENT. 2008;4(4):253–257. PubMed

Bousquet J, Farrell J, Crooks G, Hellings P, Bel EH, Bewick M, et al. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) Clin Transl Allergy. 2016;6:29. PubMed PMC

Cagnani CE, Sole D, Diaz SN, Zernotti ME, Sisul JC, Borges MS, et al. Allergic rhinitis update and its impact on asthma (ARIA 2008). Latin American perspective. Rev Alerg Mex. 2009;56(2):56–63. PubMed

Kalayci O, Yorgancioglu A, Kalyoncu F, Khaltaev AN, Bousquet J. Allergic rhinitis and its impact on asthma update (ARIA 2008): the Turkish perspective. Turk J Pediatr. 2008;50(4):307–312. PubMed

Mullol J, Valero A, Alobid I, Bartra J, Navarro AM, Chivato T, et al. Allergic rhinitis and its impact on asthma update (ARIA 2008): the perspective from Spain. J Investig Allergol Clin Immunol. 2008;18(5):327–334. PubMed

Pali-Scholl I, Pohl W, Aberer W, Wantke F, Horak F, Jensen-Jarolim E, et al. Allergic rhinitis and its impact on asthma (ARIA update 2008) The Austrian perspective. Wien Med Wochenschr. 2009;159(3–4):87–92. PubMed

Pawankar R, Bunnag C, Chen Y, Fukuda T, Kim YY, Le LT, et al. Allergic rhinitis and its impact on asthma update (ARIA 2008)–western and Asian-Pacific perspective. Asian Pac J Allergy Immunol. 2009;27(4):237–243. PubMed

Yorgancioglu A, Kalayci O, Kalyoncu AF, Khaltaev N, Bousquet J. Allergic rhinitis and its impact on asthma update (ARIA 2008). The Turkish perspective. Tuberk Toraks. 2008;56(2):224–231. PubMed

Bousquet J, Schunemann HJ, Zuberbier T, Bachert C, Baena-Cagnani CE, Bousquet PJ, et al. Development and implementation of guidelines in allergic rhinitis - an ARIA-GA2LEN paper. Allergy. 2010;65(10):1212–1221. PubMed

Brozek JL, Akl EA, Alonso-Coello P, Lang D, Jaeschke R, Williams JW, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy. 2009;64(5):669–677. PubMed

Brozek JL, Akl EA, Compalati E, Kreis J, Terracciano L, Fiocchi A, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations. Allergy. 2011;66(5):588–595. PubMed

Brozek JL, Akl EA, Jaeschke R, Lang DM, Bossuyt P, Glasziou P, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines: part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies. Allergy. 2009;64(8):1109–1116. PubMed

Brozek JL, Baena-Cagnani CE, Bonini S, Canonica GW, Rasi G, van Wijk RG, et al. Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update. Allergy. 2008;63(1):38–46. PubMed

Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126(3):466–476. PubMed

Padjas A, Kehar R, Aleem S, Mejza F, Bousquet J, Schunemann HJ, et al. Methodological rigor and reporting of clinical practice guidelines in patients with allergic rhinitis: QuGAR study. J Allergy Clin Immunol. 2014;133(3):777–783. PubMed

Caimmi D, Baiz N, Tanno LK, Demoly P, Arnavielhe S, Murray R, et al. Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control. Clin Exp Allergy. 2017;47(12):1526–1533. PubMed

Bousquet J, Bewick M, Arnavielhe S, Mathieu-Dupas E, Murray R, Bedbrook A, et al. Work productivity in rhinitis using cell phones: the MASK pilot study. Allergy. 2017;72(10):1475–1484. PubMed

Bousquet J, VandenPlas O, Bewick M, Arnavielhe S, Bedbrook A, Murray R, et al. The Work Productivity and Activity Impairment Allergic Specific (WPAI-AS) Questionnaire Using Mobile Technology: the MASK Study. J Investig Allergol Clin Immunol. 2018;28(1):42–44. PubMed

Bousquet J, Arnavielhe S, Bedbrook A, Fonseca J, Morais Almeida M, Todo Bom A, et al. The Allergic Rhinitis and its impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: the MASK study. Allergy. 2018;73(2):505–510. PubMed

Bousquet J, Devillier P, Anto JM, Bewick M, Haahtela T, Arnavielhe S, et al. Daily allergic multimorbidity in rhinitis using mobile technology: a novel concept of the MASK study. Allergy. 2018;73(8):1622–1631. PubMed

Bousquet J, Devillier P, Arnavielhe S, Bedbrook A, Alexis-Alexandre G, van Eerd M, et al. Treatment of allergic rhinitis using mobile technology with real-world data: the MASK observational pilot study. Allergy. 2018;73(9):1763–1774. PubMed

Brozek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, et al. Allergic Rhinitis and its impact on asthma (ARIA) guidelines—2016 revision. J Allergy Clin Immunol. 2017;140(4):950–958. PubMed

Bousquet J, Meltzer EO, Couroux P, Koltun A, Kopietz F, Munzel U, et al. Onset of action of the fixed combination intranasal azelastine-fluticasone propionate in an allergen exposure chamber. J Allergy Clin Immunol Pract. 2018;6(5):1726–1732. PubMed

Garcia-Aymerich J, Benet M, Saeys Y, Pinart M, Basagana X, Smit HA, et al. Phenotyping asthma, rhinitis and eczema in MeDALL population-based birth cohorts: an allergic comorbidity cluster. Allergy. 2015;70(8):973–984. PubMed

Amaral R, Bousquet J, Pereira AM, Araujo LM, Sa-Sousa A, Jacinto T, et al. Disentangling the heterogeneity of allergic respiratory diseases by latent class analysis reveals novel phenotypes. Allergy. 2018 doi: 10.1111/all.13670. PubMed DOI

Siroux V, Ballardini N, Soler M, Lupinek C, Boudier A, Pin I, et al. The asthma-rhinitis multimorbidity is associated with IgE polysensitization in adolescents and adults. Allergy. 2018;73(7):1447–1458. PubMed

Siroux V, Boudier A, Nadif R, Lupinek C, Valenta R, Bousquet J. Association between asthma, rhinitis and conjunctivitis multimorbidities with molecular IgE sensitization in adults. Allergy. 2018 doi: 10.1111/all.13676. PubMed DOI

Bousquet J, Samolinski B. Allergy and active and healthy ageing. In: Akdis C, Agache I, Demoly P, Hellinbgs P, Muraro A, Papadopoulos N, et al., editors. Global atlas of allergy European Academy of Allergy and Clinical Immunology 2014. p. 379–81.

Morais-Almeida M, Pite H, Pereira AM, Todo-Bom A, Nunes C, Bousquet J, et al. Prevalence and classification of rhinitis in the elderly: a nationwide survey in Portugal. Allergy. 2013;68(9):1150–1157. PubMed

Baptist AP, Nyenhuis S. Rhinitis in the elderly. Immunol Allergy Clin North Am. 2016;36(2):343–357. PubMed PMC

Ventura MT, Gelardi M, D’Amato A, Buquicchio R, Tummolo R, Misciagna G, et al. Clinical and cytologic characteristics of allergic rhinitis in elderly patients. Ann Allergy Asthma Immunol. 2012;108(3):141–144. PubMed

Ohta K, Bousquet PJ, Aizawa H, Akiyama K, Adachi M, Ichinose M, et al. Prevalence and impact of rhinitis in asthma. SACRA, a cross-sectional nation-wide study in Japan. Allergy. 2011;66(10):1287–1295. PubMed

Samolinski B, Fronczak A, Wlodarczyk A, Bousquet J. Council of the European Union conclusions on chronic respiratory diseases in children. Lancet. 2012;379(9822):e45–e46. PubMed

Samolinski B, Fronczak A, Kuna P, Akdis CA, Anto JM, Bialoszewski AZ, et al. Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union. Allergy. 2012;67(6):726–31. PubMed PMC

Council conclusions on Healthy Ageing across the Lifecycle. 3206th Employment, social policy, ehalth and consumer affairs Council meeting. Brussels, 7 December 2012. http://wwwconsiliumeuropaeu/uedocs/cms_data/docs/pressdata/en/lsa/134097pdf. 2012.

Bousquet J, Tanasescu C, Camuzat T, Anto J, Blasi F, Neou A, et al. Impact of early diagnosis and control of chronic respiratory diseases on active and healthy ageing: a debate at the European Union Parliament. Allergy. 2013;68(5):555–61. PubMed

Muraro A, Fokkens WJ, Pietikainen S, Borrelli D, Agache I, Bousquet J, et al. European symposium on precision medicine in allergy and airways diseases: report of the European Union parliament symposium (October 14, 2015) Allergy. 2016;71(5):583–587. PubMed

Muraro A, Steelant B, Pietikainen S, Borrelli D, Childers N, Callebaut I, et al. European symposium on the awareness of allergy: report of the promotional campaign in the European Parliament (26–28 April 2016) Allergy. 2017;72(2):173–176. PubMed

Bousquet J, Dahl R, Khaltaev N. Global alliance against chronic respiratory diseases. Allergy. 2007;62(3):216–223. PubMed

Yorgancioglu A, Cruz AA, Bousquet J, Khaltaev N, Mendis S, Chuchalin A, et al. The global alliance against respiratory diseases (GARD) country report. Prim Care Respir J. 2014;23(1):98–101. PubMed PMC

Bousquet J, Bachert C, Canonica GW, Casale TB, Cruz AA, Lockey RJ, et al. Unmet needs in severe chronic upper airway disease (SCUAD) J Allergy Clin Immunol. 2009;124(3):428–433. PubMed

Bousquet J, Mantzouranis E, Cruz AA, Ait-Khaled N, Baena-Cagnani CE, Bleecker ER, et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol. 2010;126(5):926–938. PubMed

De Greve G, Hellings PW, Fokkens WJ, Pugin B, Steelant B, Seys SF. Endotype-driven treatment in chronic upper airway diseases. Clin Transl Allergy. 2017;7:22. PubMed PMC

Hellings PW, Fokkens WJ, Bachert C, Akdis CA, Bieber T, Agache I, et al. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis—an EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy. 2017;72(9):1297–1305. PubMed

Hellings PW, Fokkens WJ, Akdis C, Bachert C, Cingi C, Dietz de Loos D, et al. Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today? Allergy. 2013;68(1):1–7. PubMed

Spencer G, Corbin JH, Miedema E. Sustainable development goals for health promotion: a critical frame analysis. Health Promot Int. 2018 doi: 10.1093/heapro/day036. PubMed DOI

Morton S, Pencheon D, Squires N. Sustainable Development Goals (SDGs), and their implementation: a national global framework for health, development and equity needs a systems approach at every level. Br Med Bull. 2017;124(1):81–90. PubMed

Bousquet J, Anto JM, Demoly P, Schunemann HJ, Togias A, Akdis M, et al. Severe chronic allergic (and related) diseases: a uniform approach–a MeDALL–GA2LEN–ARIA position paper. Int Arch Allergy Immunol. 2012;158(3):216–231. PubMed

Ait-Khaled N, Enarson D, Bousquet J. Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management. Bull World Health Organ. 2001;79(10):971–979. PubMed PMC

Bousquet J, VanCauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma (ARIA)—executive summary. Allergy. 2002;57(9):841–55. PubMed

Bachert C. Allergic rhinitis and its impact on asthma (ARIA)–what does it mean for the future of SIT? Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 2003;94:229–235. PubMed

Bachert C, van Cauwenberge P. The WHO ARIA (allergic rhinitis and its impact on asthma) initiative. Chem Immunol Allergy. 2003;82:119–126. PubMed

Bousquet J, Van Cauwenberge P, Bachert C, Canonica GW, Demoly P, Durham SR, et al. Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA) Allergy. 2003;58(3):192–197. PubMed

Demoly P, Allaert FA, Lecasble M, Bousquet J. Validation of the classification of ARIA (allergic rhinitis and its impact on asthma) Allergy. 2003;58(7):672–675. PubMed

ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy. Allergic rhinitis and its impact on asthma. Allergy. 2004;59(4):373–87. PubMed

Bousquet J, Bindslev-Jensen C, Canonica GW, Fokkens W, Kim H, Kowalski M, et al. The ARIA/EAACI criteria for antihistamines: an assessment of the efficacy, safety and pharmacology of desloratadine. Allergy. 2004;59(Suppl 77):4–16. PubMed

Plavec D. ARIA–one airway, one disease: what links our research to the concept? Arh Hig Rada Toksikol. 2004;55(2–3):135–140. PubMed

Up-to-date Mexican consensus in Allergic Rhinitis and its Impact on Asthma, 2005. ARIA. Rev Alerg Mex. 2005;52(1):51–64. PubMed

Bonini S, Bonini M, Bousquet J, Brusasco V, Canonica GW, Carlsen KH, et al. Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN. Allergy. 2006;61(6):681–692. PubMed

Bousquet J, van Cauwenberge P, Ait Khaled N, Bachert C, Baena-Cagnani CE, Bouchard J, et al. Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN) Allergy. 2006;61(9):1086–1096. PubMed

Passalacqua G, Bousquet PJ, Carlsen KH, Kemp J, Lockey RF, Niggemann B, et al. ARIA update: I-Systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol. 2006;117(5):1054–1062. PubMed

Antonicelli L, Micucci C, Voltolini S, Senna GE, Di Blasi P, Visona G, et al. Relationship between ARIA classification and drug treatment in allergic rhinitis and asthma. Allergy. 2007;62(9):1064–1070. PubMed

Bousquet PJ, Bousquet-Rouanet L, Co Minh HB, Urbinelli R, Allaert FA, Demoly P. ARIA (Allergic Rhinitis and Its Impact on Asthma) Classification of Allergic Rhinitis Severity in Clinical Practice in France. Int Arch Allergy Immunol. 2007;143(3):163–169. PubMed

Bousquet PJ, Combescure C, Neukirch F, Klossek JM, Mechin H, Daures JP, et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy. 2007;62(4):367–372. PubMed

Baiardini I, Braido F, Tarantini F, Porcu A, Bonini S, Bousquet PJ, et al. ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review. Allergy. 2008;63(6):660–669. PubMed

Mendez NH, Velazquez AC, del Rivero HL, Hernandez VL, Espinola RG, Mondragon GR. Increased knowledge of ARIA and GINA guides 2006 to general physicians by an educational intervention. Rev Alerg Mex. 2008;55(5):201–205. PubMed

Singh AB, Shahi S. Aeroallergens in clinical practice of allergy in India—ARIA Asia Pacific Workshop report. Asian Pac J Allergy Immunol. 2008;26(4):245–256. PubMed

Zhang L, Han DM. An introduction of allergic rhinitis and its impact on asthma (ARIA) 2008 update. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2008;43(7):552–557. PubMed

Shah A, Pawankar R. Allergic rhinitis and co-morbid asthma: perspective from India—ARIA Asia-Pacific Workshop report. Asian Pac J Allergy Immunol. 2009;27(1):71–77. PubMed

del Cuvillo A, Montoro J, Bartra J, Valero A, Ferrer M, Jauregui I, et al. Validation of ARIA duration and severity classifications in Spanish allergic rhinitis patients: the ADRIAL cohort study. Rhinology. 2010;48(2):201–205. PubMed

Van Hoecke H, Van Cauwenberge P, Thas O, Watelet JB. The ARIA guidelines in specialist practice: a nationwide survey. Rhinology. 2010;48(1):28–34. PubMed

Jauregui I, Davila I, Sastre J, Bartra J, del Cuvillo A, Ferrer M, et al. Validation of ARIA (Allergic Rhinitis and its Impact on Asthma) classification in a pediatric population: the PEDRIAL study. Pediatr Allergy Immunol. 2011;22(4):388–392. PubMed

Yorgancioglu A, Ozdemir C, Kalayci O, Kalyocu AF, Bachert C, Baena-Cagnani CE, et al. ARIA (Allergic rhinitis and its impact on asthma) achievements in 10 years and future needs. Tuberk Toraks. 2012;60(1):92–97. PubMed

Hellings PW, Fokkens WJ, Bachert C, Akdis CA, Bieber T, Agache I, et al. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis: a EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy. 2017;72(9):1297–1305. PubMed

Ivancevich JC, Neffen H, Zernotti ME, Asayag E, Blua A, Ciceran A, et al. ARIA 2016 executive summary: integrated care pathways for predictive medicine throughout the life cycle in Argentina. Rev Alerg Mex. 2017;64(3):298–308. PubMed

Yorgancioglu AA, Kalayci O, Cingi C, Gemicioglu B, Kalyoncu AF, Agache I, et al. ARIA 2016 executive summary: integrated care pathways for predictive medicine across the life cycle. Tuberk Toraks. 2017;65(1):32–40. PubMed

Amaral R, Fonseca JA, Jacinto T, Pereira AM, Malinovschi A, Janson C, et al. Having concomitant asthma phenotypes is common and independently relates to poor lung function in NHANES 2007-2012. Clin Transl Allergy. 2018;8:13. PubMed PMC

Bousquet J, Bodez T, Gehano P, Klossek JM, Liard F, Neukirch F, et al. Implementation of guidelines for allergic rhinitis in specialist practices: a randomized pragmatic controlled trial. Int Arch Allergy Immunol. 2009;150(1):75–82. PubMed

Summary of product characteristics. Acarizax 12 SQ-HDM oral lyophilisate. European Medicines Agency. https://mricts-mrpeu/Human/Downloads/DE_H_1947_001_FinalSPCpdf. 2016.

Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol. 1994;94(2 Pt 1):182–188. PubMed

Samreth D, Arnavielhe S, Ingenrieth F, Bedbrook A, Onorato GL, Murray R, et al. Geolocation with respect to personal privacy for the Allergy Diary app: a MASK study. World Allergy Organ J. 2018;11(1):15. PubMed PMC

Bousquet J, Anto JM, Akdis M, Auffray C, Keil T, Momas I, et al. Paving the way of systems biology and precision medicine in allergic diseases: The MeDALL success story. Allergy. 2016;71(11):1513–1525. PubMed PMC

Bousquet J, Burney PG, Zuberbier T, Cauwenberge PV, Akdis CA, Bindslev-Jensen C, et al. GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma ‘epidemic’. Allergy. 2009;64(7):969–977. PubMed

Yorgancioglu AA, Gemicioglu B, Kalayci O, Kalyoncu AF, Cingi C, Murray R, et al. MASK (Mobile Airways Sentinel networK) in Turkey-the ARIA integrated mobile solution for allergic rhinitis and asthma multimorbidity. Tuberk Toraks. 2018;66(2):176–181. PubMed

Gomez RM, Gonzalez-Diaz SN, Urrutia-Pereira M, Valentin-Rostan M, Yanez A, Jares E, et al. 2017 Brussels agreement for Latin America: an initiative of the GARD and Slaai. Rev Alerg Mex. 2018;65(3):137–141. PubMed

Bousquet J, Agache I, Aliberti MR, Angles R, Annesi-Maesano I, Anto JM, et al. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA)—EIP on AHA Twinning Reference Site (GARD research demonstration project) Allergy. 2018;73(1):77–92. PubMed

Bousquet J, Schunemann HJ, Hellings PW, Arnavielhe S, Bachert C, Bedbrook A, et al. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. J Allergy Clin Immunol. 2016;138(2):367–374. PubMed

Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK-air Study

Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air® approach

Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2 LEN consensus

Helsinki by nature: The Nature Step to Respiratory Health